Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.6400
+0.0850 (15.32%)
Jul 31, 2026, 4:10 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 158.01 million as of July 31, 2026. Its market cap has increased by 102.48% in one year.
Market Cap
158.01M
Enterprise Value
150.89M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
ChartMarket Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 158.01M, an increase of 514.71%. That is a compound annual growth rate of 31.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 158.01M | -42.00% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 191.94M |
| Actinogen Medical | 151.80M |
| Dimerix | 150.10M |
| Alterity Therapeutics | 118.54M |
| Island Pharmaceuticals | 113.93M |
| Recce Pharmaceuticals | 112.30M |
| Paradigm Biopharmaceuticals | 95.04M |
| Prescient Therapeutics | 86.22M |